Skip to main content
Quest Diagnostics

Genetic Testing Symptomatic Patients for Childhood Onset Huntington’s Disease

NSGC 2024 43rd Annual Conference

National Society of Genetic Counselors

New Orleans, LA, Sep 17-21, 2024

Poster presentation: Genetic Testing Symptomatic Patients for Childhood Onset Huntington’s Disease

Authors: Powis Z, Liaquat K, Lutz J, Meservey M, Hoffman CA, Donohue K, Batish SD

Specialty: Genetics, Neurology, Pediatrics

Related content

Conference Presentation
Expanding the Phenotype of Extremely Early Onset Juvenile Huntington’s Disease
Conference Presentation
Multiplex Detection and Quantification of Neurological Disease-Associated Repeat Expansions Using the PacBio Sequel II Platform
Audio Podcast
Patient-minded Neurology
Publication
Current State of Pediatric Reference Intervals and the Importance of Correctly Describing the Biochemistry of Child Development: A Review

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.